Op deze pagina een overzicht van toekomstige evenementen en webinars. Het overzicht wordt regelmatig bijgewerkt en voorzien van nieuwe congressen, symposia, webinars en andere evenementen. Ontbreekt er een evenement? Meldt het mij via het contactformulier.
An overview of upcoming events and webinars can be seen below. Events not listed can be reported by using the contact form.
Clinical Trials Information System (CTIS) sponsor end user training programme – January 2022
EMA offers a virtual training programme, organised by DIA, to support sponsor user preparedness for the new Clinical Trials Information System and the new way of submitting a clinical trial application and managing the life cycle of a clinical trial in the European Union (EU) and European Economic Area (EEA).
3rd ESFRI RIs -EOSC Workshop: What does EOSC bring to RI users?
The main objective of the workshop is to bring together ESFRI, ESFRI RIs and EOSC stakeholders, in order to showcase and better comprehend the EOSC concept, including the Open Science and “FAIR” policy agenda, and the vision for the future, along with the EOSC value proposition for its users, and ensure an optimal federation of clusters and RIs with EOSC. The event will focus on the current state of EOSC and how the thematic RIs and ESFRI clusters fit into the developing landscape, including the partnership with the newly established EOSC Association.
FAIRsFAIR Final Event 2022
Between January 25th and 27th, FAIRsFAIR partners and stakeholders will meet for a series of concluding meetings to deep-dive into the results of FAIRsFAIR. We’ll analyse the impact that we managed to have on the European Research Community. We’ll go once more through the tools, guidelines and best practices that we have produced and delivered to researchers, data stewards, decision makers and funders towards a better, more structured approach towards FAIR data management. We’ll take the recommendations we produced and the lessons we learnt and leave them as a legacy for future activities to come.
Academic Language Experts: Should Research be Trusted? Transparency, Accuracy and Accountability in the Publication Process
Joint press briefing – The Clinical Trial Regulation enters into application in the EU
The European Medicines Agency (EMA), European Commission (EC) and Heads of Medicines Agencies (HMA) will hold a joint press briefing to provide an update on the Clinical Trial Regulation that enters into force on 31 January 2022 in the EU, and to present the Clinical Trials Information System.
ACRON lunchmeeting – VGO formulier in de praktijk
Sinds 1 november is de VGO als onderdeel van de lokale haalbaarheid procedure definitief geïmplementeerd. De ACRON wil je graag uitnodigen voor een online meeting waarin we nogmaals stilstaan bij dit document met een aantal leden van de DCRF-werkgroep lokale uitvoerbaarheid.
EFSPI Webinar: Decentralized Trials
Decentralized Trials (DCTs) were discussed at the 2021 EFSPI Workshop
on Regulatory Statistics. This session builds on that
introduction. Following a refresher on the statistical opportunities and
challenges with using decentralized trials you will hear from 2 speakers
who will focus on some real case studies where DCTs have been used in
practice. The first of these will focus on the use of digital endpoints and
provide examples of successfully using digital endpoints in clinical trials
together with flagging up some areas where further statistical work is
required. The second of these presentations will introduce a framework to
guide teams on the scientific issues related to the use of DCTs,
particularly in later phases of clinical development. Opportunities,
assumptions and points to consider will be illustrated with examples of
decentralized trials. The webinar will finish with a panel discussion where
we welcome questions from all statistical aspects of the use of DCTs in
clinical development.
NEN: Webinar over de IVDR
NEN organiseert op 31 januari a.s. van 14.30 tot 16.00 uur een webinar over de IVDR. Tijdens dit webinar staat behandeling van vragen centraal. Deelnemers kunnen vooraf vragen indienen die vooraf (geanonimiseerd) worden gedeeld met de deelnemende experts. Dit webinar wordt georganiseerd om alle partijen op het gebied van In-vitro diagnostica, waaronder fabrikanten, leveranciers en medische laboratoria, bij elkaar te brengen. Aanmelden kan tot 20 januari as.
Healixia New Year’s Event
Innovatiecafé Patiëntparticipatie bij innovatie
Op donderdag 3 februari vindt de volgende editie van het Innovatiecafé plaats. Ditmaal staat het thema ‘patiëntparticipatie’ centraal. We bespreken samen met experts op dit gebied over de laatste trends en geven ondernemers in de zorg en andere zorgprofessionals handvatten en concrete tips. Ook worden er ervaringen uitgewisseld en is er mogelijkheid tot netwerken.
EUCROF: 6th European Conference on Clinical Research
How will the world for clinical research evolve in the near future? What are the main changes in the new era, the new opportunities and what kind of challenges might we have to overcome? Listen to the experts in the different fields, i.e., the EU Commission, the European Medicines Agency (EMA), ethic committees‘ representatives, industry, academia, and patient representatives and learn about what we are to expect in the years to come.
RDA in the Netherlands by SURF/DANS /LCRDM
Purpose of event:
– sharing the way RDA works
– sharing the activities within RDA undertaken by those working in the Netherlands
– brainstorming if and how RDA outputs can be shared more and better among peers in the Netherlands
– planning future activities
UK Biobanking Showcase
Organised by the UKCRC Tissue Directory and Coordination Centre, the UK Biobanking Showcase is the UK’s leading event for those who work in biobanking and human tissue research.
Smart Hub Flemish Brabant and flanders.healthTech: 4th ‘Life-on-Chip Conference – Initiating Convergence in Health Technologies’
Micro- and nanotechnology, artificial intelligence, robotics, novel manufacturing technologies and big data are making major impacts across all industries, but perhaps their greatest potential impact is in health and life sciences. Combined with ever-growing biological insights and discoveries, resulting innovations enable fascinating applications that accelerate and transform the healthcare system. We will present testimonials of roads travelled and lessons learned from pioneering researchers, entrepreneurs and first application movers. You can attend a plenary session on data science and health followed by 4 thematic sessions covering increased efficiency in the healthcare system through the introduction of new technologies, solutions for patient specific treatment, digital diagnostics & therapeutics, and shifting the boundaries of knowledge at the forefront of medicine and healthcare.
UKRIO research integrity webinar: Research Integrity in Practice Research
The next webinar in the series of monthly sessions from the UK Research Integrity Office will be focused on research integrity in practice based research. This webinar is aimed at research students; early-career researchers; and team leaders, principal investigators, managers, supervisors, research integrity officers and others who wish to make sure their are informed about issues of good research practice.
EFGCP: Implementing “Good Lay Summary Practice”
The “Roadmap Initiative to Good Lay Summary Practice” aims to develop a pragmatic, broadly accepted framework for LS planning, development, translation and dissemination.
In this virtual 3 afternoons Workshop the key content of GLSP will be presented and hopes and hurdles for its implementation raised on Day 1. On Day 2 participants will be able to join 2 out of 4 Break-out Sessions of their choice in which concrete proposals will be worked out on how best to prepare our communities for the respective particularly challenging aspects of GLSP. On Day 3 the results from these Break-out Sessions will be presented, jointly discussed and conclusions proposed to inspire the European Commission’s and the Roadmap’s second important objective: the implementation of GLSP in clinical research daily practice including training opportunities for all involved stakeholders.
Inserm: International workshop “Towards Ethical Guidance to Protect Healthy Volunteers in Biomedical Research”
This meeting aims at being a place of discussion between the major actors of the biomedical research involving Healthy Volunteers, coming from industrialized countries and from countries with lower economic incomes. Our objectives are, on the one hand, to identify the various research projects that expose these highly vulnerable participants and on the other hand, through exchanges between the actors gathered, to propose recommendations to allow a more ethical accompaniment of these research.
FMS: Landelijke conferentie over Generieke PROMs
CBG Wetenschapsdag 2022 ‘Strengthening academic drug development: how to move forward with confidence?’
We nemen het huidige landschap van academische geneesmiddelenontwikkeling nader onder de loep. Hoe kan maximale impact van onderzoek, geïnitieerd door academische centra bereikt worden? Het inspirerende programma geeft een update van het Europese STARS-project gericht op “Strengthening Training of Academia in Regulatory Science”. Het programma bevat presentaties van prominente sprekers, onder meer dr. Saco de Visser (FAST, ZonMW), Ambassadeur Clémence Ross-van Dorp (Ministerie van Economische Zaken), prof. Jaap Verweij (KNAW, Erasmus MC) en prof. Bert Leufkens (Universiteit Utrecht). In interactieve discussies zullen we belemmeringen identificeren, initiatieven bespreken die zijn genomen om de kloof tussen onderzoek en regelgeving te dichten, en reflecteren op welke manier academische geneesmiddelenontwikkeling ondersteund kan worden.
MEB Science Day 2022
Academia play a key role in drug discovery and development. Indeed, many important advances in clinical practice, including innovative medicines, have their roots in academia. Nevertheless, bringing a drug to the market has proven to be challenging and demanding for academic drug researchers. These challenges have been attributed in part to lacking knowledge of regulatory requirements and skills in navigating the regulatory system. The MEB tries to reach out to academic drug developers, e.g., through its active involvement in training of future Dutch clinical pharmacologists, teaching activities and internships of master students of various Dutch universities, and through its participation in the EU funded Coordination and Support Action on Strengthening Training of Academia in Regulatory Science (CSA STARS; https://www.csa-stars.eu/). The MEB recognizes the value of further advancing the dialogue among academia, regulatory authorities and other stakeholders, such as patient and health-care professional representatives, and health-technology assessment bodies. Building up innovation platforms and experience-sharing networks will foster the timely exchange of information between main players and will facilitate the implementation of academic research findings in clinical practice. This year, the MEB Regulatory Science Day will focus on the current landscape of academic drug development and will address the questions on how to ensure the maximum impact of academic research and its “regulatory readiness”. Through discussions and presentations from invited speakers, we will identify what regulatory-related barriers hamper the translation of novel products or new treatment paradigms initiated in academia, discuss what initiatives have been put in place to close the gap between research and regulation, and reflect on how to make the road of academic drug development, albeit challenging, a rewarding one.
Healixia: Innovation in Healthcare: Current and future trends
In this webinar, Giovanni Briganti will introduce the field of AI in healthcare, starting from a scientific standpoint to clinical applications, as well as the promise and challenges that it entails for the Belgian Landscape.
EU-PEARL: Registration for webinar on non-concurrent controls in platform trials
This webinar will be dedicated to the use of controls in platform trials. What you can expect from this webinar:
– EU-PEARL perspective on non-concurrent control data in platforms trials
– Positions and experiences with the use of non-concurrent control data in platform trials shared by an expert panel from regulatory, academic and industry statisticians
– Panel discussion on challenges and opportunities in integrating non-concurrent control data
Decentralized Clinical Trials
FDA, MHRA and Health Canada: Good Clinical Practice Workshop: Global Clinical Trials
Topics Covered
> Key aspects of building resilience into clinical trials
> Risk-based approach to sponsor oversight
> Use of real-world data/real-world evidence
> Updates regarding decentralized trials
> Changes in clinical trial activities and inspections
> Sponsor oversight of vendors
> Potential uses of artificial intelligence and machine learning in clinical trials
> Clinical and bioanalytical challenges in bioequivalence trials
> Updates in guidance and inspection approaches
The COVID-19 pandemic has necessitated flexibility in clinical trial conduct and accelerated changes in the clinical trial landscape. Moving forward, it will be important to leverage the use of innovative tools and approaches to trial design, conduct, and inspections. This event will build on the February 2020 GCP Symposium: Data Integrity in Global Clinical Trials – Tackling Challenging Topics in 2020. Presenters will provide regulatory perspectives on how maximizing our understanding and use of risk-based approaches can build resilience into clinical trials, allowing flexibility in the protocol and clinical trial conduct while still ensuring participant safety and reliable results. Presenters will discuss continuing developments in decentralized trials, use of real-world data and real-world evidence in regulatory decision making, and the importance of sponsor oversight. The event will also include sessions dedicated to the conduct of bioequivalence (BE) trials. Regulators will provide their perspectives on common issues and challenges in the conduct of the clinical and bioanalytical components of BE trials and provide important updates on guidance and inspection activities.
Nordic Biobank Conference “Current trends and challenges in the Nordic countries”
The 1st Nordic Biobank Conference is a unique opportunity to meet representatives in the area of human biobanking as well as other scientific experts from healthcare, academia, and industry! Come and listen to the latest news and current trends in human biobanking, while networking with professional colleagues. The conference is jointly organized by the Nordic countries, comprised of Denmark, Finland, Iceland, Norway and Sweden.
ZonMw: Bijeenkomst verankering sekse en gender in onderzoek
Op dinsdagmiddag 8 maart 2022 organiseert ZonMw een bijeenkomst om de openstaande subsidieoproep ‘Verankering van sekse en gender in onderzoek’ en de nieuwe taakopdracht ‘Gender en Gezondheid’ nader toe te lichten.
MHRA: Good Pharmacovigilance Practice
NVFG Voorjaarscongres
AFPT-Le Club Phase 1 & EUFEMED: Course: “Pre-Clinical and Clinical Safety in Early Development Human Trials”
DIA Europe 2022
DIA Europe 2022 is designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need for your everyday job. Your participation will accelerate your growth and your organization’s performance in the drug development ecosystem.
ZonMw: Congres Goed Gebruik Geneesmiddelen
FMS: Symposium Zorgevaluatie in de volgende versnelling
Nordic Life Science Days 2022
Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business.
CDISC 2022 Europe Interchange
The 2022 CDISC Europe Interchange is an event consisting of workshops, training courses, and a two-day Main Conference. This event will provide an opportunity to share progress, implementation experiences, and strategic ideas on world wide data interchange standards for medical research.
ALLEA: Transforming Science – Pathways Towards Sustainability and Trustworthiness
ISBER 2022 Hybrid Annual Meeting and Exhibits
Biobanking is increasingly recognized as intrinsic for accelerating the scientific journey. By fostering deep collaboration amongst a broad, inclusive community of thought leaders, we are able to strengthen our collective capability and create shared value. The challenges associated with providing sustainable, modern infrastructure will not be solved unless there is a concerted effort to integrate lessons learned into a robust ecosystem built on partnerships across multiple sectors. Partnerships must be broad, creative, expansive and committed to the collective impact. Such coalitions can be multi-sectorial and include leaders and stakeholders from diverse quarters representing academia, industry, and government, each of whom bring their own experiential knowledge and assets. Biobanks must provide scientists and the general community with globally-available tools to innovate, learn, and inspire. As the world grows ever more connected aided by the convergence of biology, data, digital systems and automated technologies, biobanking presents many new potential applications. From novel companion diagnostics, which can be used to diagnose and treat disease more effectively, to enhancing our understanding of environmental influences, biobanking is shaping the scientific journey in a new world. Hear experts share their stories behind Biobanking: Shaping the Scientific Journey, and help build a new understanding of the biobanking landscape to contribute to a strong vision for the future.
EBSA Conference 2022
The SARS-CoV-2 pandemic impacts society in unseen ways, pushing biosafety practices in everyday situations, and with a strengthened public interest in containment and safety measures. At the same time biosafety professionals had to reorient themselves to cope with extraordinary situations, requiring creative solutions. Building on this dynamic, the EBSA 2022 Conference will be the meeting place where biosafety professionals can reconnect, share effective and practical approaches, and thereby accelerate Biosafety.
NVFG ClinOpsdag 2022
ECRIN: International Clinical Trials Day (ICTD) 2022: Recruitment in Clinical Trials
The topic will be Recruitment in Clinical Trials. Stay tuned for more information.
Flanders.bio: Knowledge for Growth
knowledge for growth is Europe’s finest life sciences conference. The event features an exciting programme providing vital insight into the global life sciences’ landscape, one-to-one partnering, a trade fair and more!